XYL Financial Statements & Analysis
Complete financial statements for XYL including income statement, balance sheet, and cash flow statement. Analyze XYL's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
68
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
16.3% ↑
Net Income
46.1% ↑
Gross Margin
1.7% ↑
Operating Margin
33.1% ↑
Balance Sheet
Current Ratio
-0.5% ↓
Debt to Equity
-15.1% ↑
Asset Turnover
13.6% ↑
Cash Flow
Operating Cash Flow
50.9% ↑
Net Cash Flow
36.0% ↑
Free Cash Flow
66.4% ↑
Cash Flow to Debt
69.7% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 7.36B | 8.56B | 16.3% | |
| Gross Profit | 2.72B | 3.21B | 18.2% | |
| Operating Income | 652.00M | 1.01B | 54.8% | |
| Net Income | 609.00M | 890.00M | 46.1% | |
| EPS | 2.81 | 3.67 | 30.6% | |
| EBITDA | 1.12B | 1.69B | 51.2% | |
| Gross Margin | 36.90% | 37.51% | 1.7% | |
| Operating Margin | 8.85% | 11.78% | 33.1% | |
| Net Income Margin | 8.27% | 10.39% | 25.7% | |
| R&D Expenses | 232.00M | 230.00M | 0.9% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 8.56B | 7.36B | 5.52B | 5.20B | 4.88B |
| Gross Profit | 3.21B | 2.72B | 2.08B | 1.98B | 1.83B |
| Operating Income | 1.01B | 652.00M | 622.00M | 585.00M | 495.00M |
| Net Income | 890.00M | 609.00M | 355.00M | 427.00M | 254.00M |
| EPS | 3.67 | 2.81 | 1.97 | 2.37 | 1.41 |
| EBITDA | 1.69B | 1.12B | 726.00M | 832.00M | 613.00M |
| Gross Margin | 37.51% | 36.90% | 37.74% | 38.02% | 37.53% |
| Operating Margin | 11.78% | 8.85% | 11.26% | 11.26% | 10.15% |
| Net Income Margin | 10.39% | 8.27% | 6.43% | 8.22% | 5.21% |
| R&D Expenses | 230.00M | 232.00M | 206.00M | 204.00M | 187.00M |